Ticker: PASG

Snapshot - Passage Bio, Inc. (PASG) (NASDAQ) What's happening inside: the company executed a major restructuring in Jan 2025 (≈55% workforce reduction) and ceased Hopewell lab operations, out‑licensed several pediatric lysosomal programs to Gemma, and is concentrating resources on its lead clinic...